{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:27:19Z","timestamp":1783711639367,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004253","name":"Quaid-i-Azam University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004253","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.heliyon.2023.e18059","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T05:27:15Z","timestamp":1689571635000},"page":"e18059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Immunoinformatic and reverse vaccinology-based designing of potent multi-epitope vaccine against Marburgvirus targeting the glycoprotein"],"prefix":"10.1016","volume":"9","author":[{"given":"Hassan","family":"Yousaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6514-5417","authenticated-orcid":false,"given":"Anam","family":"Naz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naila","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubashir","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Obaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faryal Mehwish","family":"Awan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Sikander","family":"Azam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e18059_bib1","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3389\/fimmu.2020.01663","article-title":"Designing multi-epitope vaccines to combat emerging coronavirus disease 2019 (COVID-19) by employing immuno-informatics approach","volume":"11","author":"Naz","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e18059_bib2","first-page":"2804","volume":"47","author":"Hoover","year":"2003","journal-title":"Antimicrobial characterization of human \u03b2-defensin 3 derivatives"},{"key":"10.1016\/j.heliyon.2023.e18059_bib3","first-page":"1663","volume":"11","author":"Naz","year":"2020","journal-title":"Designing multi-epitope vaccines to combat emerging coronavirus disease 2019 (COVID-19) by employing immuno-informatics approach"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e18059_bib4","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3390\/v4101878","article-title":"Forty-five years of Marburg virus research","volume":"4","author":"Brauburger","year":"2012","journal-title":"Viruses"},{"issue":"15\u201316","key":"10.1016\/j.heliyon.2023.e18059_bib5","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.vaccine.2003.10.027","article-title":"The societal value of universal childhood vaccination","volume":"22","author":"Chabot","year":"2004","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e18059_bib6","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/C5SC03892H","article-title":"Peptide-based synthetic vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem. Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e18059_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/vaccines2030515","article-title":"Peptide vaccine: progress and challenges","volume":"2","author":"Li","year":"2014","journal-title":"Vaccines"},{"issue":"1851","key":"10.1016\/j.heliyon.2023.e18059_bib8","article-title":"Why does drug resistance readily evolve but vaccine resistance does not?","volume":"284","author":"Kennedy","year":"2017","journal-title":"Proc. Biol. Sci."},{"key":"10.1016\/j.heliyon.2023.e18059_bib9","first-page":"63","article-title":"In silico CD4+, CD8+ T-cell and B-cell immunity associated immunogenic epitope prediction and HLA distribution analysis of Zika virus","volume":"16","author":"Janahi","year":"2017","journal-title":"EXCLI journal"},{"issue":"20","key":"10.1016\/j.heliyon.2023.e18059_bib10","doi-asserted-by":"crossref","first-page":"8426","DOI":"10.1073\/pnas.1019030108","article-title":"T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus","volume":"108","author":"Kondratowicz","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18059_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/0974-777X.77299","article-title":"Fundamentals of vaccine immunology","volume":"3","author":"Clem","year":"2011","journal-title":"J. Global Infect. Dis."},{"issue":"24","key":"10.1016\/j.heliyon.2023.e18059_bib12","doi-asserted-by":"crossref","first-page":"12060","DOI":"10.1128\/JVI.01650-06","article-title":"CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system","volume":"80","author":"Sitati","year":"2006","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18059_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40203-021-00080-3","article-title":"Vaccinomics approach for scheming potential epitope-based peptide vaccine by targeting l-protein of Marburg virus","volume":"9","author":"Pervin","year":"2021","journal-title":"In silico pharmacology"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e18059_bib14","first-page":"779","article-title":"Novel adjuvants & delivery vehicles for vaccines development: a road ahead","volume":"138","author":"Mohan","year":"2013","journal-title":"The Indian journal of medical research"},{"issue":"13","key":"10.1016\/j.heliyon.2023.e18059_bib15","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.vaccine.2013.01.041","article-title":"Modulation of HIV peptide antigen specific cellular immune response by synthetic \u03b1-and \u03b2-defensin peptides","volume":"31","author":"Mohan","year":"2013","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e18059_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1471-4906(02)02246-9","article-title":"Mammalian defensins in immunity: more than just microbicidal","volume":"23","author":"Yang","year":"2002","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18059_bib17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12026-013-8428-5","article-title":"Nasal delivery of PLG microparticle encapsulated defensin peptides adjuvanted gp41 antigen confers strong and long-lasting immunoprotective response against HIV-1","volume":"58","author":"Mohan","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.heliyon.2023.e18059_bib18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fmicb.2016.00206","article-title":"Differential expression of miRNA regulates T cell differentiation and plasticity during visceral leishmaniasis infection","volume":"7","author":"Pandey","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.heliyon.2023.e18059_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.meegid.2016.12.010","article-title":"Immunoinformatics analysis and in silico designing of a novel multi-epitope peptide vaccine against Staphylococcus aureus","volume":"48","author":"Hajighahramani","year":"2017","journal-title":"Infect. Genet. Evol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e18059_bib20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/bit.21396","article-title":"Strategy for selecting and characterizing linker peptides for CBM9\u2010tagged fusion proteins expressed in Escherichia coli","volume":"98","author":"Kavoosi","year":"2007","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.heliyon.2023.e18059_bib21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.meegid.2015.03.027","article-title":"Identification of putative vaccine candidates against Helicobacter pylori exploiting exoproteome and secretome: a reverse vaccinology based approach","volume":"32","author":"Naz","year":"2015","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.heliyon.2023.e18059_bib22","series-title":"The Proteomics Protocols Handbook","author":"Walker","year":"2005"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18059_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep36617","article-title":"PEPlife: a repository of the half-life of peptides","volume":"6","author":"Mathur","year":"2016","journal-title":"Sci. Rep."},{"issue":"47","key":"10.1016\/j.heliyon.2023.e18059_bib24","doi-asserted-by":"crossref","first-page":"32043","DOI":"10.1021\/acsomega.1c04817","article-title":"Designing of a multi-epitope vaccine against the structural proteins of Marburg virus exploiting the immunoinformatics approach","volume":"6","author":"Sami","year":"2021","journal-title":"ACS Omega"},{"issue":"47","key":"10.1016\/j.heliyon.2023.e18059_bib25","doi-asserted-by":"crossref","first-page":"18631","DOI":"10.1073\/pnas.0702130104","article-title":"Human \u03b2-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2","volume":"104","author":"Funderburg","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18059_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-19456-1","article-title":"Novel immunoinformatics approaches to design multi-epitope subunit vaccine for malaria by investigating anopheles salivary protein","volume":"8","author":"Pandey","year":"2018","journal-title":"Sci. Rep."},{"issue":"17","key":"10.1016\/j.heliyon.2023.e18059_bib27","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.vaccine.2018.03.042","article-title":"Immunoinformatics approaches to design a novel multi-epitope subunit vaccine against HIV infection","volume":"36","author":"Pandey","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18059_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-03990-6","article-title":"In silico construction of a multiepitope Zika virus vaccine using immunoinformatics tools","volume":"12","author":"Antonelli","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18059_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-67749-1","article-title":"A candidate multi-epitope vaccine against SARS-CoV-2","volume":"10","author":"Kar","year":"2020","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e18059_bib30","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1080\/07391102.2020.1770127","article-title":"Design of multi-epitope vaccine candidate against SARS-CoV-2: a in-silico study","volume":"39","author":"Abraham Peele","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18059_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-73371-y","article-title":"Designing a multi-epitope peptide based vaccine against SARS-CoV-2","volume":"10","author":"Singh","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e18059_bib32","doi-asserted-by":"crossref","first-page":"13069","DOI":"10.1021\/acsomega.9b00944","article-title":"Strategic development of a next-generation multi-epitope vaccine to prevent Nipah virus zoonotic infection","volume":"4","author":"Ojha","year":"2019","journal-title":"ACS Omega"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e18059_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253393","article-title":"Immunoinformatics and molecular dynamics approaches: next generation vaccine design against West Nile virus","volume":"16","author":"Khan","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e18059_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10989-022-10406-0","article-title":"An Immunoinformatic strategy to develop new Mycobacterium tuberculosis multi-epitope vaccine","volume":"28","author":"Ghandadi","year":"2022","journal-title":"Int. J. Pept. Res. Therapeut."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18059_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-09199-w","article-title":"Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection","volume":"7","author":"Ali","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023052672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023052672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:37:28Z","timestamp":1783114648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023052672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2405844023052672"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18059","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoinformatic and reverse vaccinology-based designing of potent multi-epitope vaccine against Marburgvirus targeting the glycoprotein","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e18059"}}